A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa

Clinical trial NCT01000740 · COMPLETED

Trial details

NCT number: NCT01000740
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2009-08-01
Primary completion: 2010-04-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.